Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
about
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesPerspectives on menopause and women with HIVChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsInfluence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusExpanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, CanadaLate HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaVirological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012Focus Group Evaluation of the LIVE Network-An Audio Music Program to Promote ART Adherence Self-Management.The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsSex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewCost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region.Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to CareA phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.Nigerian dental technology students and human immunodeficiency virus infection: knowledge, misconceptions and willingness to care.Sex with older partners is associated with primary HIV infection among men who have sex with men in North CarolinaEconomic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial dataCase series of fertility treatment in HIV-discordant couples (male positive, female negative): the Ontario experienceTh17, gut, and HIV: therapeutic implicationsProspective study of bone mineral density changes in aging men with or at risk for HIV infection.The impact of HIV-1 on neurogenesis: implications for HANDDisparities in the burden of HIV/AIDS in CanadaGlycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines.Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.At the coalface and the cutting edge: general practitioners' accounts of the rewards of engaging with HIV medicine.Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.Meta-analyses of fertility desires of people living with HIVTrends in plasma HIV-RNA suppression and antiretroviral resistance in British Columbia, 1997-2010Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.The impact of unstable housing on emergency department use in a cohort of HIV-positive people in a Canadian setting.Learning from Interviews with HIV-Discordant Couples (Male Positive, Female Negative): The Challenges and SuccessesCohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational studySafety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label studyLife expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.Independent effects of HIV, aging, and HAART on brain volumetric measures.Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.Use of antineoplastic agents in patients with cancer who have HIV/AIDS.Improved survival in HIV treatment programmes in AsiaThe effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
P2860
Q24597052-C3477AC3-3C32-4834-A166-BEA8D335C108Q26772852-DF8F8318-6D62-4A06-AFFD-0268CAC86E45Q26781511-0A1AFA61-4CE5-4418-94E7-CE211F10E531Q26851535-F39AC5EE-F336-4484-9A3E-D88B9F27CF7DQ28474271-1E773D15-22A9-417F-B8D6-367116A202C0Q28474749-3A77B05B-FA23-4066-A256-37FF2FD480EFQ28537704-0CCDA57C-5742-4CD8-9BAA-38AB867F5180Q28539652-75A28D05-35DC-48EB-9073-082132BE4C70Q30353427-69698D8C-57DE-4166-92EF-E66D2DAC121FQ33505475-26C14354-00FB-48AC-B973-616F95FF96A2Q33566578-0BE37AA3-3317-4109-AE8D-92CEBCB5E581Q33628836-CA0AFABC-BAF6-43C1-9233-6EB01E01F946Q33668524-E3E4CA09-D3D0-413D-8BEC-8DECB4CE1385Q33686288-EAEAFBB3-F584-45E6-BBE1-6AEFC3988ADDQ33809468-955FB278-F914-4AB8-8EE2-60370714F2D8Q33882095-87866A72-A3E4-4608-BF9A-AF095895913FQ33891656-119BDDC5-D6CB-42CA-AABC-EF68088BA27BQ34039447-6B5F51E0-8027-468B-9A54-0C1A1D95BA39Q34050602-8F8E1F31-A962-42B9-B80F-1280C065CE3EQ34116648-4172B86A-2C00-42A8-8F00-464F8FED1898Q34472345-91FE353D-BC2E-4C02-98BE-F057320FA572Q34499532-2FC8F69B-B2CF-4A25-9CB8-5865558553CEQ34539440-DB37D503-9418-48B2-8AC7-59EBB63C17A4Q34547116-6013FAAB-6AB8-4E2F-9609-319C88E8CA11Q34630931-3607724C-2004-4D39-B6C2-79A349F63625Q34667707-146F8867-CED5-48D8-B687-789CF025B13DQ34694474-05475FD8-0CF8-48A8-A322-AABDEE3D94A0Q34702301-894B130B-C5EB-4CF9-A2B0-B5C9E4D32E17Q34722581-72929703-6B5E-4B43-B4C9-54E1E9501854Q34788721-BE793DD9-00B1-4CD4-ACF2-A8E9AB346B5CQ35013012-79CCDB0A-9FAF-4DF8-8063-0D829915E824Q35119311-BB182071-A7F8-492D-93DF-ABC046B0C899Q35232696-5CE5A411-346F-4A71-B648-00A7CDDAF909Q35623357-607D3C81-9C78-4E51-B824-FE154B93EE95Q35693918-38753D9A-0D8E-4886-BA6E-9FE669AE183EQ35827867-0AE55EB7-3242-414A-A983-1AFA0906BB62Q35873534-677CB426-F821-47E9-A750-1B5E7AADEA32Q35932561-DA67058A-56A3-453A-9793-573122A56A4CQ35951760-00C2FC0D-0CF9-4340-B075-3A34087448DDQ35962516-8B518135-154F-42B0-B1FD-FB81167B2247
P2860
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Continued improvement in survi ...... active antiretroviral therapy.
@ast
Continued improvement in survi ...... active antiretroviral therapy.
@en
Continued improvement in survi ...... active antiretroviral therapy.
@nl
type
label
Continued improvement in survi ...... active antiretroviral therapy.
@ast
Continued improvement in survi ...... active antiretroviral therapy.
@en
Continued improvement in survi ...... active antiretroviral therapy.
@nl
prefLabel
Continued improvement in survi ...... active antiretroviral therapy.
@ast
Continued improvement in survi ...... active antiretroviral therapy.
@en
Continued improvement in survi ...... active antiretroviral therapy.
@nl
P2093
P50
P1433
P1476
Continued improvement in survi ...... active antiretroviral therapy.
@en
P2093
Benita Yip
David Moore
P Richard Harrigan
Viviane D Lima
P304
P356
10.1097/QAD.0B013E32802EF30C
P407
P577
2007-03-01T00:00:00Z